Skip to main content


The Group's work was focused on cardiovascular and neurovascular chronic diseases, with the aim to develop and apply methods to detect and quantify early diseases while reversible.


The Group's primary research goal was to build and apply integrative, individualised heart models based on patient data that are capable of early disease detection and prediction. This is most relevant to the epidemic of heart failure, a condition which currently lacks accurate methods of early measurement and diagnosis. Further priority research focused on the development and application of the accurate measure of currently “invisible” brain damage, secondary to cardiovascular disease or chronic disorders. The Group aimed to improve practices and therefore the outcome of disease progression.

By using imaging techniques to better understand cardiac disease, the Group hoped to improve the accuracy and ease of diagnosis and use this knowledge to improve patient care.

HRI breakthrough drug for coronavirus

Read full article